Evaluation of Tuberculosis Treatment Outcomes

CompletedOBSERVATIONAL
Enrollment

111

Participants

Timeline

Start Date

May 8, 2023

Primary Completion Date

November 9, 2023

Study Completion Date

December 12, 2023

Conditions
Tuberculosis
Interventions
OTHER

Patients with turberculosis

The study plans to collect data from patients with microbiological confirmation of tuberculosis, notified to the SS Hospital Infection Surveillance and Control Antimicrobial Stewardship, in the period between 2019 and 2023, taken in charge by the SC Infectious Diseases of the A.O. SS Antonio e Biagio and Cesare Arrigo of Alessandria (Piedmont Region, Italy).

Trial Locations (1)

15121

Clinical Trial Center, Alessandria

All Listed Sponsors
lead

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

OTHER

NCT06942975 - Evaluation of Tuberculosis Treatment Outcomes | Biotech Hunter | Biotech Hunter